Cancer immunotherapy: dendritic-cell vaccines on the move
/in Dendritic Cells, International PublicationsA novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells
/in Dendritic Cells, International PublicationsPhase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
/in Dendritic Cells, International Publications, Pancreatic CancerImmunotherapy for lung cancer: for whom the bell tolls?
/in Dendritic Cells, International Publications, NSCLCDendritic cell-based vaccine efficacy: aiming for hot spots
/in Dendritic Cells, International PublicationsComparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell
/in Dendritic Cells, International Publications, Pancreatic CancerMatched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsCellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
/in Dendritic Cells, International Publications, Ovarian CancerDendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer